Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets Proceedings of a Symposium (2018) / Chapter Skim
Currently Skimming:
Appendix B: Biographical Sketches of Committee Members, Presenters, and Moderators
Appendix B: Biographical Sketches of Committee Members, Presenters, and Moderators
Pages 55-64
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 55... ...
, a company founded in 2009 with the goal of establishing a medical radioisotope production facility in the United States. Prior to founding Coquí Pharma, Bigles co-founded and served as chief financial officer of the Caribbean Radiation Oncology Center in Puerto Rico.
|
From page 56... ...
He had technical responsibility for transference of technology of Mo-99 production with LEU to the Australian Nuclear Science and Technology Organisation, the Egyptian Atomic Energy Authority, the Nuclear Research Center of Draria, Algeria, and the Board of Radiation and Isotope Technology (BRIT) in India.
|
From page 57... ...
as a research programme officer in the Joint Research Centre's (JRC's) Euratom Coordination Unit, responsible mainly for the coordination of nuclear security and nuclear science application activities, including cooperation between the EC and the International Atomic Energy Agency (Seibersdorf and Monaco labs)
|
From page 58... ...
Carolyn Haass is the chief operating officer of Northwest Medical Isotopes. She has more than 30 years of experience in multidisciplinary complex nuclear, chemical, hazardous, and mixed waste engineering, procurement, construction, and project management projects in both the government and private industry.
|
From page 59... ...
Mang'era was previously director of the radiopharmacy for Winnipeg Health, a technical/ scientific leader for the Prairie Isotope Production Enterprise, and head of the Radiopharmaceuticals Research Group. In these roles, he led critical research initiatives into isotope production technologies prior to joining the commercialization private company, CIIC, as a founder and COO.
|
From page 60... ...
From 2004 through 2005, he served as an expert to the International Atomic Energy Agency Nuclear Fuel Subcommittee. For the past several years, he has served as coordinator of the RAS and National Academy of Sciences committees on counterterrorism and nonproliferation.
|
From page 61... ...
Meera Venkatesh is director of the Division of Physical and Chemical Sciences in the Department of Nuclear Applications at the International Atomic Energy Agency (IAEA)
|
From page 62... ...
Prior to his employment at INR he was a research scientist at the Joint Institute for Nuclear Research, an international research center for nuclear sciences located at Dubna, Moscow Oblast. Zhuikov is author and co-author of more than 200 scientific and popular science publications including a review of medical isotope production in Russia. He is a member of the Scientific Council of the Institute for Nuclear Research of the Russian Academy of Sciences, the Russian Society of Nuclear Medicine, the American Nuclear Society, and the International Society of Nuclear Chemistry.
|
From page 63... ...
She held a reactor operator license on the UVA Reactor and worked in the commercial nuclear power industry as a startup engineer, plant systems engineer, and reactor engineer for 9 years prior to working at INL. Tom Hanlon is a nuclear engineer in the Research Reactor Section at the International Atomic Energy Agency, responsible for project activities related to the low-enriched uranium conversions of Miniature Neutron Source Reactors (MNSRs)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.